Use of toxicity assays for enantiomeric discrimination of pharmaceutical substances

Chirality

Volumn 21, Issue 8, 2009, Pages 751-759

  de Andrés, Fernando ^a   Castañeda, Gregorio ^a   Ríos, Ángel ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Enantiomeric effects; Pharmaceutical drugs; Stereoselective toxicity; Toxicity assays; Water environments

Indexed keywords

ATENOLOL; DOPA; FLUOXETINE; LEVODOPA;

AQUATIC ENVIRONMENT; ARTICLE; CONTROLLED STUDY; DAPHNIA; DRUG STRUCTURE; ECOTOXICITY; ENANTIOMER; ENANTIOSELECTIVITY; GROWTH INHIBITION; MICROALGA; NONHUMAN; PRIORITY JOURNAL; PSEUDOKIRCHNERIELLA SUBCAPITATA; TETRAHYMENA THERMOPHILA; TOXICITY TESTING;

ALGAE, GREEN; ANIMALS; ATENOLOL; DIHYDROXYPHENYLALANINE; FLUOXETINE; MOLECULAR STRUCTURE; PROTOZOA; STEREOISOMERISM; TOXICITY TESTS; TOXINS, BIOLOGICAL; WATER POLLUTANTS, CHEMICAL;

EID: 70349556073     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20675     Document Type: Article

References (29)

1. Ferrari B, Paxéus N, Lo Giudice R, Pollio A, Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid and diclofenac. Ecotoxicol Environ Saf 2003;55:359-370.
2. Halling Sorensen B, Holten Lützhoft HC, Andersen HR, Ingerslev F. Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin. J Antimicrob Chemother 2000;46 (suppl. 1):53-58.
3. Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 1999;107 (suppl. 6):907-938.
4. Pedersen JA, Soliman M, Suffet IH. Human pharmaceuticals, hormones, and personal care product ingredients in runoff from agricultural fields irrigated with treated wastewater. J Agric Food Chem 2005;53:1625-1632.
5. Hernando MD, Fernández-Alba AR, Tauler R, Barcelo D. Toxicity assays applied to wastewater treatment. Talanta 2005;65:358-366.
6. Cleuvers M. Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere 2005;59:199-205.
7. Brooks BW, Foran CM, Richards SM, Weston J, Turner PK, Stanley JK, Solomon KR, Slattery M, La Point TW. Aquatic ecotoxicology of fluoxetine. Toxicol Lett 2003;142:169-183.
8. Hernando MD, Mezcua M, Fernández-Alba AR, Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006;69:334-342.
9. Stanley JK, Ramirez AJ, Chambliss CK, Brooks BW. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007;69:9-16.
10. Fono LJ, Sedlak DL. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ Sci Technol 2005;393:9244-9252.
11. Wong CS. Environmental fate processes and biochemical transformations of chiral emerging organic pollutants. Anal Bioanal Chem 2006;386:544-558.
12. Protoxkit F™. Freshwater toxicity test with a ciliate protozoan. Standard Operational Procedure. Creasel: Deinze, Belgium; 1998.
13. Daphtoxkit F™ magna. Crustacean toxicity screening test for freshwater. Standard Operational Procedure. Creasel: Deinze, Belgium; 1996.
14. OECD. OECD guidelines for testing of chemicals. Section 2, effects on biotic systems. Daphnia sp. Acute immobilisation test and reproduction test 1984; Protocol 202:1-16.
15. ISO. Water quality: determination of the inhibition of the mobility of Daphnia magna Straus (Cladocera, Crustacea). ISO 6341. Geneva: International Organization for Standardization; 1996.
16. Commission of the European Communities. Methods for determination of ecotoxicity; Annex V, C. 2, Daphnia, acute toxicity to Daphnia L 383A, EEC Directive 92/69/EEC 1992;172-178.
17. Algaltoxkit F™. Freshwater toxicity test with microalgae. Standard Operational Procedure. Creasel: Deinze, Belgium; 1996.
18. OECD. OECD Guidelines for Testing of Chemicals. Section 2, effects on biotic systems. Alga growth inhibition test. Method 201. Paris, France: OECD; 1984.
19. ISO. Water quality: fresh water algal growth inhibition test with Scenedesmus subspicatus and Selenastrum capricornutum. ISO 8692. Geneva: International Organization for Standardization; 1989.
20. Commission of the European Communities. Methods for determination of ecotoxicity; Annex V, C. 3, Algal inhibition test, L 383A, EEC Directive 92/69/EEC 1993;179-186.
21. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 2003;144:383-395.
22. ECOSAR database. Available at: http://www.uoguelph.ca/~hsander.
23. Isnard P, Flammarion P, Roman G, Babut M, Bastien Ph, Bintein S, Esserméant L, Férard JF, Gallotti-Schmitt S, Saouter E, Saroli M, Thiébaud H, Tomassone R, Vindimian E. Statistical analysis of regulatory ecotoxicity tests. Chemosphere 2001;45:659-669.
24. Muna L, Persoone G, Janssen C, DeCoen W, Svardal K. Toxicity evaluations of wastewaters in Austria with conventional and cost-effective bioassays. Ecotoxicol Environ Saf 1995;32:139-146.
25. Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism - chronic treatment with L-dopa. N Engl J Med 1969;280:337-345.
26. Mehvar R, Brocks DR. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans. J Pharm Pharm Sci 2001;4:185-200.
27. Zuccato E, Calamari D, Natangelo M, Fanelli R. Presence of therapeutic drugs in the environment. Lancet 2000;355:1789-1790.
28. Brooks BW, Turner PK, Stanley JK, Weston JJ, Glidewell EA, Foran CM, Slattery M, La Point TW, Huggett DB. Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 2003;52:135-142.
29. Muñoz-Bellido JL, Muñoz-Criado S, García-Rodríguez JA. Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int J Antimicrob Agents 2000;14:177-180.